By: Natalie E. Gonzales
Hidden Connections Between Epilepsy and Other Neurological Conditions
Introduction
Epilepsy is a neurological disorder that affects the nerve cells, leading to an imbalance of signaling as a result of unusual electrical activity occurring in the brain, causing seizures. As society progresses, it has been estimated that 1.2% of the U.S. population has epilepsy. An individual with epilepsy may have other health conditions (Mayo Clinic). This can occur because epilepsy may cause additional conditions, the associated conditions may trigger epilepsy, or a shared underlying mechanism might be present alongside epilepsy and these other conditions. As research advances, it is becoming clear that epilepsy shares biological roots with conditions such as autism, ADHD, Alzheimer’s disease, and depression.
This is imperative as it influences not only the progression of epilepsy but also its effects on an individual’s general brain health and quality of life. Grasping these connections enables researchers to discover new treatment options and methods that enhance outcomes for individuals affected by epilepsy (Powell, 2024).
Shared Pathophysiology Mechanisms
A major theme across recent studies is that many brain conditions, including epilepsy, share common biological pathways. For example, both epilepsy and Alzheimer’s disease involve neuroinflammation, or chronic immune activation within the brain. According to Liew et al. (2023), ongoing inflammation triggers changes in the brain’s immune cells (microglia), increases the levels of inflammatory molecules such as IL-1β and TNF-α, and can render neurons more excitable, thereby setting the stage for both seizures and neurodegeneration.
Beyond inflammation, researchers like Stasenko et al. (2024) have found that white matter network disruption also plays a big role. White matter is what connects different regions of the brain, allowing them to communicate. When these connections are damaged, whether by epilepsy, injury, or other conditions, it can lead to issues with cognition, emotion, and behavior. Essentially, it is not where seizures start that matters, but how the brain networks are wired and rewired over time.
Neurological Comorbidities
Individuals with epilepsy are more likely to encounter additional neurological disorders. Research has demonstrated significant mutual relationships between epilepsy and conditions such as stroke, migraines, and neurodevelopmental disorders like ADHD and autism. According to Seidenberg and Hermann (2009), there are three main ways these comorbidities can develop:
1. Epilepsy (or its treatments) may directly cause another condition
2. The other condition (or its treatment) may make someone more likely to develop epilepsy
3. Both may stem from a shared underlying cause, such as genetic vulnerability or abnormal brain development
This shared-cause model is gaining increasing support from modern research. For example, a genetic variant or prenatal brain change might alter both brain circuitry and neurotransmitter function, predisposing someone to seizures and attention problems at the same time.
Psychiatric and Cognitive Comorbidities
Beyond the neurological connections, epilepsy often coexists with mental health and cognitive challenges. Depression, anxiety, and memory issues are among the most commonly reported comorbidities (Mayo Clinic, 2025). Some of these challenges may come from the social and psychological stress of living with a chronic condition. However, biologically, there is also evidence that disruptions in neurotransmitters, white matter networks, and inflammatory signaling pathways contribute to changes in mood and cognition.
In fact, Stasenko et al. (2024) found that white matter disconnections in certain brain regions, such as those connecting the temporal lobe to the frontal and limbic areas, are strongly linked with both psychiatric symptoms and cognitive impairment in people with epilepsy. This helps explain why treatments that focus solely on controlling seizures do not always improve a person’s overall well-being; the broader network disruptions need to be addressed, too.
Clinical and Research Implications
Understanding the shared mechanisms between epilepsy and other brain disorders changes how we think about both treatment and prevention. Instead of treating each condition separately, researchers are now exploring how connectivity could potentially help with both epilepsy and Alzheimer’s disease. Organizations are now funding studies that use advanced neuroimaging, genetic analyses, and biomarker tracking to pinpoint exactly how these disorders overlap. As Powell (2024) emphasizes, the goal is to move from simply controlling seizures to improving the entire spectrum of brain health.
Scientists have made major progress in understanding how epilepsy connects with other brain conditions, but there are still many unanswered questions. Future studies are now focusing on several key areas:
1. Longitudinal studies and causal relationships – researchers like Siedenberg and Hermann (2009) stress the need for long-term studies that track how and when comorbid conditions develop. Does depression appear because of epilepsy, or do both arise from the same brain changes? Understanding this timing could reshape prevention and treatment strategies.
2. Molecular and genetic mechanisms – There is increasing interest in identifying the shared genetic inflammatory pathways that underlie epilepsy, autism, and Alzheimer’s disease. For example, scientists are exploring whether targeting specific cytokines or microglial activation could slow both seizures and neurodegeneration.
3. Advanced imaging and biomarkers – New techniques in neuroimaging and connectomics (studying brain network organization) could help identify early warning signs of comorbid conditions. Stasneko et al. (2024) propose that measures of white matter connectivity might one day predict which patients are at higher risk for cognitive or psychiatric complications.
4. Personalized and network-based therapies – Instead of “one-size-fits-all” seizure control, future treatments may use a network neuroscience approach, targeting not just the seizure focus the larger disrupted brain circuits. Combining anti-inflammatory drugs, neuromodulation, and rehabilitation strategies could offer more comprehensive care.
5. Quality of life and holistic care – Beyond biology, researchers are emphasizing the importance of addressing mental health, cognition, and daily function. Future clinical studies aim to integrate psychological support and cognitive training into standard epilepsy management.
Epilepsy research can likely focus on integrating neuroscience, genetics, and mental health, aiming for a complete understanding of how the brain’s networks, chemistry, and structure shape the lived experience of epilepsy and its related conditions.
Conclusions
Epilepsy is just one piece of a much bigger puzzle concerning brain network dysfunction, with inflammation, genetics, and connectivity all playing interconnected roles. By exploring these relationships, researchers are revealing not only the reasons behind seizures but also why many individuals with epilepsy face additional cognitive or emotional difficulties. Investigating epilepsy within the broader context of overall brain health, rather than viewing it as a standalone issue, provides the greatest opportunity to enhance the lives of millions worldwide.
References:
Liew, Y., Retinasamy, T., Arulsamy, A., Ali, I., Jones, N. C., O’Brien, T. J., & Shaikh, M. F. (2023). Neuroinflammation: A common pathway in Alzheimer’s disease and epilepsy. Journal of Alzheimer’s Disease, 94(2), 547–564. https://doi.org/10.3233/JAD-230059
Mayo Clinic Staff. (2025, October 14). Epilepsy — Symptoms & Causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/epilepsy/symptoms-causes/syc-20350093
Powell, N. (2024, May 31). Understanding the Links Between Epilepsy and Other Brain Conditions. Epilepsy Research Institute. https://epilepsy-institute.org.uk/eri/research/features/understanding-the-links-between-epilepsy-an d-other-brain-conditions/
Seidenberg, M., & Hermann, B. (2009). Association of epilepsy and comorbid conditions. Epilepsy & Behavior, 14(Suppl 1), S1–S10. https://pmc.ncbi.nlm.nih.gov/articles/PMC2802344/
Stasenko, A., Lin, C., Bonilha, L., Bernhardt, B. C., & McDonald, C. R. (2024). Neurobehavioral and Clinical Comorbidities in Epilepsy: The Role of White Matter Network Disruption. Neuroscientist, 30(1), 105–131. https://doi.org/10.1177/10738584221076133
